|
Volumn 36, Issue 5 SUPPL. 1, 2000, Pages
|
Endothelin-A-receptor antagonist LU 135.252 Inhibits the formation of ventricular arrhythmias caused by intrapericardial infusion of endothelin-1
a a a a a a a a a |
Author keywords
Endothelin (ET); LU 135.252 (LU); Monophasic action potential duration (MAPD); Ventricular arrhythmia
|
Indexed keywords
ANTIARRHYTHMIC AGENT;
DARUSENTAN;
ENDOTHELIN 1;
ENDOTHELIN A RECEPTOR ANTAGONIST;
ACTION POTENTIAL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARRHYTHMOGENESIS;
ARTICLE;
CONTROLLED STUDY;
DOG;
DRUG MECHANISM;
ELECTROCARDIOGRAM;
ENDOCARDIUM;
EPICARDIUM;
HEART DEPOLARIZATION;
HEART LEFT VENTRICLE;
HEART MUSCLE ISCHEMIA;
HEART OUTPUT;
HEART RIGHT VENTRICLE;
HEART VENTRICLE ARRHYTHMIA;
HEART VENTRICLE FIBRILLATION;
HEART VENTRICLE TACHYCARDIA;
MEAN ARTERIAL PRESSURE;
NONHUMAN;
PRIORITY JOURNAL;
ST SEGMENT ELEVATION;
|
EID: 0033744183
PISSN: 01602446
EISSN: None
Source Type: Journal
DOI: 10.1097/00005344-200036001-00114 Document Type: Article |
Times cited : (9)
|
References (9)
|